Find Federal Grants
National Institutes of Health · PAR-21-251
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-22-039
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-21-330
National Institutes of Health · RFA-DA-22-040
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-22-028
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
National Institutes of Health · RFA-DK-21-026
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-21-332
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
National Institutes of Health · PAR-21-331
ARP Act Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Innovation Award – COVID-19 Related Data/Technology Innovations (Track Two)
Health Resources and Services Administration · HRSA-22-102
Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Innovation Award – General Data/Technology Innovations (Track One)
Health Resources and Services Administration · HRSA-22-089
National Institutes of Health · PAR-22-027
National Institutes of Health · PAR-21-324
Limited Competition for the Data Coordinating Center (DCC) for the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) (U24 Clinical Trial Optional)
National Institutes of Health · RFA-DK-21-502
NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-022
National Institutes of Health · PAR-21-323
National Institutes of Health · PAR-21-322
Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-029
Service Area Competition
Health Resources and Services Administration · HRSA-22-007
NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs) (U01 Clinical Trial Optional)
National Institutes of Health · RFA-DK-21-022
Collaborative Partnership between Research Centers in Minority Institutions (RCMI) and Alcohol Research Centers (U54 Clinical Trial Optional)
National Institutes of Health · RFA-AA-21-015